Dublin, Nov. 4, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/fsd6gv/pointofdelivery)
has announced the addition of the
"Point-of-Delivery Drug Reconstitution Systems to 2017" report
to their offering.
Growth in the number of injectable drugs supplied in solid form for
reconstitution prior to administration is being driven by the
increase in drugs based on biological NCEs. These drugs are
typically unstable at ambient temperatures and to preserve their
shelf life must be either stored at low temperature (the so-call
'cold chain') or processed into a form that will preserve their
pharmacological efficacy until they reach their therapeutic
destination. Because the cost of transporting and storing drugs
using refrigeration is expensive and requires constant temperature
monitoring to insure that the drug has not been exposed to
environmental conditions that render unsafe for use as a
therapeutic product, technologies such as lyophilization are
becoming more prevalent. The packaging and technologies developed
and marketed for safe and reliable reconstitution at the point of
administration are benefiting from this market trend. This report
examines commercial drug reconstitution devices and systems and
their impact on the injectable drug delivery sector.
Highlights
- Analyzes therapeutic demand drivers and evaluates the market
impact and potential of commercial
drug reconstitution systems
- Provides analysis of injectable drugs for reconstitution and
assesses key market segments, market dynamics and market
demographics
- Forecasts Injectable drug product demand by indication and
therapy to 2017
- Profiles reconstitution system suppliers, their product
activities, business strategies, and corporate alliances and
affiliations
Key Topics Covered
Executive Summary
Market Dynamics
Prolonging the Shelf Life of Biological Drugs
Distribution Strategies
Formulation Strategies
Lyophilization and Reconstitution at the Point of Use
Healthcare Economics and Reconstitution Systems
What's Driving the Growth in Engineered Reconstitution
Systems?
Biological Drugs Proliferating
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors
Drug Reconstitution Systems - Commercial Devices
Vial Adapters
Vial-to-Vial Systems
Needle-less Transfer Devices
Direct Connect to Vial
Direct Connect to Cartridge
Dual Chamber Syringes
Dual Chamber Cartridges
Closed Drug Transfer
Reconstitution System Design Factors
Stability and Material Selection Issues
Disposable Drug Cartridges
Single vs Multi-Dose Devices
Human Engineering/Ergonomics
Drug Reconstitution - Therapeutic Sector Analysis
Market Factors
Drug Reconstitution Systems - Company Profiles
For more information visit
http://www.researchandmarkets.com/research/fsd6gv/pointofdelivery
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Drug Delivery